MINNETONKA, Minn., U.S.A. – The Advanced Biofuels Business Council (ABBC) recently announced that a member of the Cellerate™ process technology collaboration team will take a seat on the ABBC Board of Directors. Founded in 2011 as the Advanced Ethanol Council, the ABBC’s mission is to help its members speak with one voice to put the advanced bio-refining industry in the best position to succeed.
Syngenta and Quad County Corn Processors (QCCP) are engaged in a collaboration to license Cellerate, a revolutionary, new enhancing technology that can help ethanol plants convert corn kernel fiber into cellulosic ethanol. The corn fiber ethanol pathway is approved by U.S. EPA as an RFS-eligible cellulosic biofuel. QCCP owns and operates an ethanol plant in Galva, Iowa, and is one of the leading developers of cellulosic ethanol production technology through its wholly-owned subsidiary Cellulosic Ethanol Technologies, LLC.
“The cellulosic biofuels industry is breaking through at commercial scale, and it is critical for the industry to remain unified when it comes to how we engage on policy and regulatory matters,” said Brooke Coleman, executive director of the ABBC. “Syngenta and QCCP are highly engaged on both the business and political fronts, and we look forward to working with them on strategies that will help the industry succeed in 2015 and beyond.”
In addition to enabling plants to increase production by up to 6 percent, Cellerate can help ethanol producers increase the protein content of dried distillers grains to as much as 40 percent and increase total yield of distillers corn oil up to 1.2 pounds per bushel. QCCP is currently on track to annually produce 2 million gallons of cellulosic ethanol via the Cellerate process.
“We are very excited about our ability to develop a cellulosic biofuel technology that increases ethanol throughput and corn oil extraction while reducing energy input and carbon emissions,” said Delayne Johnson, chief executive officer of QCCP. “It is this type of value proposition that makes the future of cellulosic ethanol so bright.”
Cellerate is licensed exclusively by Syngenta and will be marketed along with Enogen® corn enzyme technology. Enogen is an exclusive in-seed innovation from Syngenta and the industry's first and only biotech corn designed specifically to enhance ethanol production.
“As Syngenta continues to explore new technologies that will contribute to the future success of the ethanol industry, it is clear that the Cellerate collaboration and the Advanced Biofuels Business Council share a strong focus on facilitating the commercialization and growth of the advanced bio-refining industry,” said Jack Bernens, head of Enogen at Syngenta. “And we must continue to engage in policy discussions to ensure the long-term stability and success of advanced biofuels.”
For more information about Enogen corn enzyme technology, visit
www.Enogen.net. Join the conversation online – connect with us at
social.SyngentaUS.com.
About Syngenta
Syngenta is a leading agriculture company helping to improve global food security by enabling millions of farmers to make better use of available resources. Through world class science and innovative crop solutions, our 28,000 people in over 90 countries are working to transform how crops are grown. We are committed to rescuing land from degradation, enhancing biodiversity and revitalizing rural communities. To learn more visit
www.syngenta.com and
www.goodgrowthplan.com. Follow us on Twitter® at
www.twitter.com/Syngenta
Media Contacts:
Staci Monson
612-656-8545
staci.monson@syngenta.com
Brad Bremer
212-697-2600
bbremer@gscommunications.com
Web Resources:
Enogen Website
Syngenta Newsroom
Know More, Grow More
QCCP Website
Cautionary Statement Regarding Forward-Looking Statements
This document contains forward-looking statements, which can be identified by terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract there for.
©2015 Syngenta. 11055 Wayzata Boulevard, Minnetonka, MN 55305. Cellerate™, Enogen® and the Syngenta logo are trademarks of a Syngenta Group Company.